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Atherosclerosis is intimately coupled to blood ﬂow by the presence of predilection sites. The cou-
pling is through mechanotransduction of endothelial cells and approximately 2000 gene are associ-
ated with this process. This paper describes a new platform to study and identify new signalling
pathways in endothelial cells covering an atherosclerotic plaque. The identiﬁed networks are syn-
thesized in primary cells to study their reaction to ﬂow. This synthetic approach might lead to
new insights and drug targets.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction a better predictor of plaque composition than plaque size or (bulk)Coronary heart disease (CHD) is the global leading cause of
death. In the UK, acute coronary syndromes (ACS) cause 60% of
CHD deaths and lead to240,000 hospitalizations each year, incur-
ring direct healthcare costs of £1.7 billion annually. The majority
of the mortality of CHD is related to the rupture of a thin cap ﬁbro-
atheroma (TCFA). The characteristics of a rupture-prone plaque are
that of a large and soft lipid-rich necrotic core covered by a thin
and inﬂamed ﬁbrous cap [1,2]. Associated features include big pla-
que size, expansive remodelling preventing luminal obstruction
(mild stenosis by angiography), neo-vascularization, plaque haem-
orrhage, adventitial inﬂammation, and a ‘‘spotty’’ pattern of calci-
ﬁcations [1,2]. While cross sectional composition of plaques is
known and have been described extensively, the longitudinal het-
erogeneity of plaques has recently attracted more attention [3–5].
The rediscovery of longitudinal plaque heterogeneity exposed
an essential role for blood ﬂow determining plaque composition.
Recent studies, including ours, showed that (local) shear stress iscal Societies. Published by Elsevier
sSAM, cell speciﬁc SAM; CV,
et enrichment analysis; PCA,
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.cholesterol levels [1,3,6–10]. To further investigate the role of
shear stress in plaque composition, we induced two different pro-
atherogenic shear stress ﬁelds (low, non-oscillatory and low, oscil-
latory shear stress patterns) in a straight vessel of hypercholestere-
mic, ApoE / mice and demonstrated that speciﬁc shear stress
patterns induced speciﬁc plaque compositions, when ApoE /
mice were exposed to a high cholesterol environment [11–13].
Interestingly, the low, non-oscillatory shear stress pattern induced
TCFAs, while the low and oscillatory shear stress induced stable
plaques [12–15]. Further studies indicated that TCFA formation
was associated with the presence of adhesion factors, chemokines,
and activating factors for macrophages [12–15], indicating that the
reduction of blood velocity enhanced inﬂammation in the plaques.
These observations have recently been conﬁrmed in pig coronary
arteries, and in human carotid and coronary vessels indicating that
blood ﬂow and its derivative, shear stress (which scales linearly to
velocity) is fundamental to determining plaque composition
[16–18].
All studies above indicate that the ﬂow-directed phenotype of
the endothelial cell determines the processes leading to TCFA
formation. Endothelial cells are known to contain a variety of
mechanosensors and two decades of research have identiﬁed that
seven-nine endothelial pathways are modiﬁed by mechanical
stimulation. These mechano-sensitive pathways regulate eight
acknowledged transcription factors, which lead to the expression
of 2000 genes [7,19–24]. The sheer number of mechano-sensitiveB.V. Open access under CC BY-NC-ND license.
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endothelial cells covering a plaque offers a challenging problem,
to identify individual signalling cascades.
Several methods are emerging from the ﬁeld of systems biology
to solve these intractable problems, which may roughly be divided
in two ways: bottom-up and top-down approaches. The bottom-up
strategy characterises small signalling networks by applying a
combination of genomics and systems biology, while exposing
cells to an environment of atherogenic risk factors [25–27]. In
the second (top-down) strategy one aims to use high throughput
genomic screens and state-of-the art bioinformatics analysis meth-
ods to identify (small) gene networks of interest [28–31]. While
both methods will lead to small networks amenable to a synthetic
biology approach, the top-down method often needs an extra step
of validation before the synthetic biology networks may be
constructed.
In this article, we describe a new platform which aims to com-
bine state-of-the-art 3-D imaging, computational modelling, cut-
ting-edge genomics, bioinformatics and systems biology to
decipher, old and new signalling pathways in endothelial cells
which will be used to rationally design new synthetic networks
aimed at treating atherosclerosis. In order to do so, we have devel-
oped a novel platform for cardiovascular studies (Fig. 1). The de-
tails of the platform will be discussed in larger detail below, and
the ﬁrst studies using (parts of) this platform are presented in this
paper. Initiatives to study these networks using synthetic methods
are also presented.
2. Material and methods
2.1. Systems and synthetic platform for vascular studies
In recent years, we have developed a comprehensive, modular
imaging platform to combine state-of-the art imaging, computa-
tional methods with 3-D histological reconstruction techniques
which enables us to couple high resolution geometry of the plaque
to shear/wall stress and protein distribution (see Fig. 2), described
before. Brieﬂy, we combine microCT with microMRI to obtain twoFig. 1. This ﬁgure describes the platform used to identify small networks from
situations where vascular disease can be mimicked realistically. To that end a
modular image–based front has been designed that captures images, segments
images and performs biomechanical calculations to isolate regions of interest. These
regions are then used to isolate cells of interest with either laser capture
techniques, or statistical deconvolution (see text for further details) in order to
obtain cellular RNA from regions of interest. This RNA is then used for high
throughput analysis with microarrays or RNA-seq, pre-processed and normalised.
The resulting set of differentially expressed genes is analysed with state-of-the art
bioinformatics software (time-dependent ARACNE) to obtain the topology of the
networks. This topology matrix is then used to solve a linear system model which
captures the ﬂux dynamics of the network of interest.contours from the lumen-vessel wall interface and from the vessel
wall-adventitia interface. These contours are used to warp the
cross sections, shrunken by their histology treatment, back into
their original geometry, allowing individual cross sections to be
reconstructed in 3-D dimensions (Fig. 2). The coupling to 3-D
histological methods – as presented here – preserves the high spa-
tial resolution needed to accurately map the large heterogeneity of
atherosclerotic plaques in small animals. A further advantage of
the current method is the usage of immunohistochemistry for pro-
tein detection, and the possibility to relate our biomechanical
parameters to a wide variety of protein distributions. The high res-
olution 3-D lumen-vessel wall reconstruction is used for computa-
tional ﬂuid dynamics. Features of the resulting stress/strain and/or
protein distributions are used to identify regions of interest on dig-
itally-derived cross sections (Fig. 3). These regions of interest steer
a robot-driven laser-capture machine-microscope system (Zeiss,
Munchen, Germany) which enables to identify and isolate cells of
interest on basis of protein distribution and/or biomechanical pro-
ﬁle. A non-contact technique is then used to isolate RNA from the
selected cells (Fig. 3).
In conditions where cellular content is too low and RNA yield
minimal, we use a statistical deconvolution technique for further
analysis. This is a statistical approach of deconvolving gene expres-
sion proﬁles obtained from heterogeneous tissue samples into
cell-type-speciﬁc sub-proﬁles. This method is based on a frame-
work ﬁrst proposed by Venet et al. [32], incorporating the assump-
tion that the gene expression in a mixture of cell types is a
weighted sum of those cell types. The weights are proportional
to the relative contribution of these cell types in the mixture and
are hence invariable among genes. Subsequent studies have dem-
onstrated that the linearity assumption is valid under a wide vari-
ety of experimental conditions, especially when the cellular
composition of the heterogeneous tissue was determined in the
same object as where the RNA was obtained from [33,34]. To
deconvolve cell-speciﬁc gene expression, we applied a statistical
methodology of csSAM which, given microarray data from two
groups of biological samples and the relative cell-type frequencies
of each sample, estimates the average gene expression for each
cell-type at a group level, and uses these cellular gene expression
levels to identify differentially expressed genes at a cell-type spe-
ciﬁc level between experimental conditions.
These gene sets are subsequently analysed by Gaussian Graph-
ical Modelling (GGM) to obtain the topology of biological networks
of interest. GGM uses partial correlation to identify direct from
indirect interactions between genes [35]. On selected networks, a
stringent Gene Enrichment Analysis (GSEA) is used to identify
groups of genes that act as a group within the network. When time
dependent data are present, analysis based upon the time-delay
ARACNE module is performed [36]. Finally, we are currently
expanding these possibilities with ODEs, using (constrained) ﬂux
balance analysis [37–40] (Fig. 4).
2.2. Platform benchmarking
In order to test this platform, we have been studying tissue
obtained from 240 ApoE / mice on a high cholesterol diet. Each
animal was instrumented with a shear stress modiﬁer, which has
been shown to induce vulnerable and stable plaques in a single
vascular segment [13,41]. The progression of plaque development
has been fully characterised in previous studies and on basis of
these studies, vascular tissue was isolated at 6 and 9 weeks of pla-
que development to study gene expression proﬁles from vulnera-
ble and stable plaque regions [13,41]. On the basis of measured
shear stress proﬁles [42], low shear stress induced vulnerable pla-
que and oscillatory shear stress stable plaque regions were se-
lected on basis of which RNA was puriﬁed using the RNeasy
Fig. 2. Different imaging input modules are used to obtain an accurate geometry of the (diseased) vessels. A preference for high spatial resolution techniques (microscopy,
micro-CT) is favoured over other techniques, albeit micro-MRI and ultrasound are often used to obtain functional information. State-of-the art segmentation techniques
(‘level-set methods’) are used to identify the vessel wall, which is subsequently used to mesh either the vessel lumen or the vessel wall applying linear mapping techniques. to
use computational techniques to obtain shear stress maps, or wall stress maps. High spatial resolution information from the vessel wall is obtained from an in-house
developed 3-D imaging technique. An example on the right side of the pictures shows the 3-D distribution of lipids in a plaque, coupled to a 3-D young modulus distribution
and a resulting mechanical stress distribution.
Fig. 3. From the 3-D colour distribution, regions in the vessel wall are isolated on features considered important for the process of interest. Colour coding may be related
either to wall or shear stress distributions obtained from computational techniques or to any protein distribution derived by immunohistochemistry. The software then
generates digital cross sections that serve as input for a robot-driven laser-capture machine. This machine automatically dissects the cells from the regions of interest and
processes them to obtain cellular RNA. As sometimes the yield of RNA is too low, we have also developed a technique based upon statistical deconvolution, which allows
obtaining cellular gene expression proﬁles from entire vessel wall, pooled RNA.
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manufacturer’s protocol. After ampliﬁcation and labelling of puri-
ﬁed RNA samples, cDNA samples were hybridized to GeneChip
Mouse Genome 430 2.0 arrays for 18 h (Affymetrix). Post-hybrid-
ization washing, scanning and image analysis were performed
according to Affymetrix protocols. The yield of RNA at 6 and
9 weeks from these regions was of high quality, but too low for a
single microarray experiment and 10 animals were subsequentlypooled for a single microarray at each time point. A total of 6
microarrays for vulnerable and stable plaques were studied at 6
and 9 weeks of cuff placement (total of 24 arrays, obtained from
240 animals: Fig. 5).
Normalisation of the microarrays was based on quartile nor-
malisation and gene-level signal estimates were generated using
the Robust Multichip Average (RMA) algorithm implemented in
Expression Console software provided by Affymetrix, including
Fig. 4. This picture describes the bioinformatics platform developed by us, where we use a combination of GGM and GSEA to identify modules of networks, followed by
ARACNE, when temporal data are present. While this approach offers the topology for a network, it does not necessary describes dynamics. This is acquired by implementing
linear systems theory based ﬂux based analysis, as a last and ﬁnal step.
Fig. 5. This picture describes the ﬁlters used to describe the analysis of the microarrays. After normalising the microarrays with RMA, we performed a principal component
analysis to identify homogeneity of sets of microarrays. Four arrays were found different than the clusters identifying each experimental condition and were deleted. The
remaining 20 arrays were ﬁltered using SCAMPA, for low expression using their mean value and for absence of change during experimental intervention using their variance.
The remaining probe set was analysed in several ways using SAM, RANKPROD and ANOVA.
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summarises probe level intensities to provide low noise level gene
expression values (Fig. 5). Next, Principal Component Analysis
(PCA) was applied on the entire microarray to identify homoge-
neous sets. The analysis revealed that four of the microarrays
LSS9W.3, OSS9W.4, LSS6W.4, LSS6W.6 deviated from the remain-
der of the set and could be identiﬁed as outliers, resulting in 20
microarray for further analysis (Fig. 5). Subsequently, several ﬁlters
were developed to improve the signal to noise ratio of the remain-
ing test. First SCAMPA was used to ﬁlter genes that were not anno-
tated. Secondly, we ﬁltered the genes whose mean value across all
samples was lower than the 5% percentile, which signiﬁes the
probe sets with lowest expression levels and correspond tobackground noise not directly relevant to our experiment. Thirdly,
we ﬁltered those genes whose Coefﬁcient of Variation (CV) ob-
tained over all samples was lower than the 5 percentile; that is,
we deleted genes which showed smallest amount of change across
all samples. After ﬁltering, the ﬁnal number of probe sets was re-
duced to 35,340 from 45,101 (Fig. 5).
3. Results
3.1. Whole-genome differential gene expression
We compared SAM and RANKPROD at a FDR level of 5% for
whole genome differential gene expression levels. For LSS6W and
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identiﬁed 3123genes and the combination of both identiﬁed
2815 genes; between groups of LSS9W and OSS9W: RankProd
identiﬁed 513 signiﬁcant genes and SAM did not detect any, so
the overlap is 0; between groups of LSS6W and LSS9W: SAM iden-
tiﬁed 580 signiﬁcant genes, RankProd identiﬁed 1152 genes and
the overlap is 225 genes; between groups of OSS6W and OSS9W,
14285 genes were identiﬁed by SAM as signiﬁcant, 3433 genes
by RankProd and the overlap is 3226 genes.
3.2. Cell-speciﬁc differential gene expression
The Iterative Boolean procedure was tested against known cell
fractions obtained from a separate series of experiments with a
good result, indicating that the method to generate posterior PDFs
of our cellular plaque compositions produced accurate results.
Implementing the posterior PDF to the deconvolution method re-
vealed new cell-speciﬁc genes that were undetected with the clas-
sical SAM method. A ﬁrst analysis, where time and location were
taken as independent variables, revealed that time was non-signif-
icant. Hence, the time-dependent samples were pooled to increase
power of the tests. As a result, the number of genes differentially
expressed between vulnerable and stable plaques were 16,645,
distributed over VSMC (1300 genes), Endothelial Cells (6300), T-
cells (4900), and Macrophages (5100).
3.3. Pathway selection
Pathway analysis was performed applying gene enrichment
analysis – which identiﬁed 49 pathways, of which 4 were activated
both in VSMC and ECs, and 45 pathways were exclusively activated
in endothelial cells. Two pathways were selected for further study:
the MAPK and PPAR pathways. The MAPK pathway is driving two
very important mechanosensitive transcription factors: the NF-
jB and KLF-2 pathways and, and consequently those TFs were fur-
ther studied in larger detail.
3.4. The NF-jB and KLF2 pathways under ﬂow
Based on the results presented above we decided to study the
dynamic behaviour of the MAPK-NF-jB pathway and the MAPK5-
KLF2 pathway in endothelial cells under well deﬁned ﬂow condi-
tions in vitro. A step response in ﬂow applied to an endothelial cell
monolayer induced an oscillation of both pathways, depending on
the level of blood ﬂow. There was, however, a clear difference be-
tween both pathways, as the period of oscillation of the NF-jB
pathway was 20 min, and that of the KLF-2 pathway was 2 h. For
both pathways, there was an increase in frequency of oscillation
when ﬂow was increased. Frequency modulation has been identi-
ﬁed as an emerging mechanism for gene regulation in a variety of
cells under a diversity of experimental conditions [43–47], making
it an important problem. At present its regulation is unknown and
our group is studying this topic applying a combination of mathe-
matical modelling and experimentation measurements.
The ﬁrst systems model we designed was the MAPK/IKK/NF-jB
pathway. This pathway is known to oscillate due to the presence of
two negative feedback loops: one consisting of Ij-B and NF-jB
interaction and the second one of A20-IKK interaction [44,48].
Our initial model predictions indicated that the ﬂow-dependent
oscillations could not be caused by the accepted feedback loops
(Ij-B and A20), and we therefore gathered experimental evidence
indicating that the regulation of the eNOS-NO pathway which is
known to be controlled by NF-jB and its related nitric oxide re-
lease offers a new level of frequency modulated regulation. By
parameter estimation techniques, taken into account NO transport
and NO-inhibition studies by LNMA, we identiﬁed an unknowninﬂuence of NO on IKK activity. Further analysis of the molecular
structure of IKK identiﬁed 3 possible sites for nitrosylation. These
sites are currently evaluated by site-directed mutagenesis.
We recently obtained evidence that, besides the oscillation of the
NF-jB pathway, the MAPK5-MEF2c-KLF2 pathway also oscillates
under ﬂow. The reason for these oscillations is currently unknown
and we have performed a microarray analysis to further elucidate
the underlying mechanism. The initial results indicate the presence
of a negative feedback loop at the level of MEF2c-KLF2 whichmight
offer a new, initial explanation for this observation.
4. Discussion
This paper describes a new platform where sophisticated 3-D
imaging and computational methods are used to identify cells of
interest on basis of biomechanical features (shear stress and wall
stress). The isolation of RNA from these cells, subsequent micro-
array analysis and statistical deconvolution methods identiﬁed a
variety of signalling pathways unknown to endothelial cells cover-
ing a vulnerable plaque. One of these pathways, the MAPK path-
way was selected for further studies, as it was one of the
strongest activated signalling pathways in endothelial cells cover-
ing the vulnerable plaque and members of this pathway have been
shown to react to blood ﬂow in cultured cells. Two transcription
factors regulated by the MAPK-pathway appeared to react to blood
ﬂow, and surprisingly oscillated with the level of blood ﬂow. Math-
ematical systems models of these pathways identiﬁed new levels
of regulation. These new ﬁndings were based upon two methods,
which will be discussed in further detail.
Deconvolution of gene expression for heterogeneous samples
can be performed accurately when sufﬁciently precise estimates
of the proportional representation of component cell types in each
sample is available and when expression proﬁles of the compo-
nents are sufﬁciently different. Cell proportions can be measured
through experimental methods such as ﬂuorescence activated cell
sorting analysis and histopathological evaluation. With known
cell-type proportions in the mixture, deconvolution can be solved
as a linear regression problem in which the cell-speciﬁc gene
expression represents the regression coefﬁcients [33,34].
When the proportions of the component cell types are unknown,
there are investigations that performed deconvolutionwith expres-
sion of signature genes in pure cell types [49]. Abbas et al. [49] de-
scribed a method to predict the proportions of white blood cell
subtypes in samples from patients with systemic lupus erythema-
tosus. First, they selected the most highly expressed signature
genes from 18 immune cells according to their expression proﬁles
for each cell population. Then they applied the expression data of
these signature genes to solve a linear equation for the proportions
of the 18 immune cell subtypes in both healthy donors and patients
with lupus. [50] Using deconvolution, they quantiﬁed the constitu-
ents of real blood samples and mixtures of immune-derived cell
lines and uncovered the correlations of leucocyte dynamics to clin-
ical variables and measures. Under circumstances where careful
preliminary studies have been conducted to identify expression
proﬁles of signature genes from pure samples that clearly distin-
guish the cell types, such deconvolution can be successful.
Without the prior measurement of cell-type proportions or the
identiﬁcation of any signature genes, some studies used a variety
of methods, such as Bayesian framework, non-negative matrix fac-
torization and logarithmic data transformations [33,34,51–54].
Erkkilä et al. formalised a probabilistic model, DSection, and
showed with simulations as well as with real microarray [55] data
that DSection attains increased modelling accuracy in terms of
estimating cell type proportions of heterogeneous tissue samples
and identifying differential expression across cell types under
various experimental conditions. They incorporated the missing
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framework through Bayesian probabilities whose shapes reﬂect
the uncertainties associated with the prior information, such as
cell-type proportions or cell-type-speciﬁc expression proﬁles. For
all model parameters, a Markov chain Monte Carlo (MCMC) sam-
pler is proposed under the assumption that the heterogeneous tis-
sues have been measured under various experimental conditions,
which may have impact on cell-type-speciﬁc expression proﬁles
[55].
We adapted this method to form a pipeline with the cell-type-
speciﬁc signiﬁcance analysis of microarray (csSAM) method devel-
oped by Shen-Orr et al. [56]. While these authors validated their
method on synthetic mixtures of liver, brain and lung cells from
rats and the mixture expression proﬁles obtained in silico turned
out to be highly correlated with the experimentally measured
expression proﬁles for the mixtures. The sub proﬁles of cell-spe-
ciﬁc expression deconvolved were in good agreement with expres-
sion measured in pure cell types for a large majority of probes. We
concluded from these measurements that the combination of Mar-
kov-chain Monte Carlo modelling and csSAM seems to be a useful
tool for analysis of gene expression from heterogeneous samples
with unknown cell proportions. Indeed, our results show a good
prediction of cell types, and a consistent gene expression at differ-
ent levels of false discovery rates. Furthermore, the discovered sig-
nalling pathways were known to be shear dependent, which was
conﬁrmed under well-controlled ﬂow conditions.
These small networks can now be tested with synthetic meth-
ods in a newly developed environment enabling to rapidly trans-
fect primary cells with a large variety of small networks, while
placed under complex biomechanical and chemical environments.
In conclusion, this paper describes a new platform that enables
to identify new disease speciﬁc networks, applying a combination
of imaging, computational modelling and state-of-the art genom-
ics. The resulting small networks can be studied in cells applying
systemic siRNA approaches, or by placement of synthetic networks
in these cells. The latter option is currently explored and will show
new promises for smart treatment of vascular disease, like athero-
sclerosis. A ﬁrst benchmark study showed promising results as
new signalling pathways were identiﬁed.
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